These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


239 related items for PubMed ID: 9986715

  • 41. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
    May LT, Avlani VA, Langmead CJ, Herdon HJ, Wood MD, Sexton PM, Christopoulos A.
    Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
    [Abstract] [Full Text] [Related]

  • 42. Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
    Voigtländer U, Jöhren K, Mohr M, Raasch A, Tränkle C, Buller S, Ellis J, Höltje HD, Mohr K.
    Mol Pharmacol; 2003 Jul; 64(1):21-31. PubMed ID: 12815157
    [Abstract] [Full Text] [Related]

  • 43. Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes.
    Waelbroeck M, Camus J, Tastenoy M, Christophe J.
    Br J Pharmacol; 1992 Jan; 105(1):97-102. PubMed ID: 1596694
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Prediction of functionally selective allosteric interactions at an M3 muscarinic acetylcholine receptor mutant using Saccharomyces cerevisiae.
    Stewart GD, Sexton PM, Christopoulos A.
    Mol Pharmacol; 2010 Aug; 78(2):205-14. PubMed ID: 20466821
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Activation of muscarinic acetylcholine receptors via their allosteric binding sites.
    Jakubík J, Bacáková L, Lisá V, el-Fakahany EE, Tucek S.
    Proc Natl Acad Sci U S A; 1996 Aug 06; 93(16):8705-9. PubMed ID: 8710935
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor.
    Grant MK, El-Fakahany EE.
    J Pharmacol Exp Ther; 2005 Oct 06; 315(1):313-9. PubMed ID: 16002459
    [Abstract] [Full Text] [Related]

  • 55. Contribution of lateral substituents in symmetrical and non-symmetrical heptane-bisammonio compounds to the allosteric stabilization of N-methylscopolamine binding to muscarinic M2 receptors.
    Staudt M, Tränkle C, Mohr K, Holzgrabe U.
    Arch Pharm (Weinheim); 2003 Aug 06; 336(8):385-9. PubMed ID: 14502759
    [Abstract] [Full Text] [Related]

  • 56. Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: studies with chimeric receptors.
    Ellis J, Seidenberg M.
    Mol Pharmacol; 2000 Dec 06; 58(6):1451-60. PubMed ID: 11093785
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Interaction studies of multiple binding sites on m4 muscarinic acetylcholine receptors.
    Lanzafame AA, Sexton PM, Christopoulos A.
    Mol Pharmacol; 2006 Aug 06; 70(2):736-46. PubMed ID: 16709648
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Dual effects of muscarinic M(2) acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists.
    Michal P, Lysíková M, Tucek S.
    Br J Pharmacol; 2001 Mar 06; 132(6):1217-28. PubMed ID: 11250872
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.